1. Liu, Fei, Deng, Yawen, Zhao, Yong, Liu, Yang, Xia, Yunlong. 2022. Time series RNA-seq analysis identifies MAPK10 as a critical gene in diabetes mellitus-induced atrial fibrillation in mice. In Journal of molecular and cellular cardiology, 168, 70-82. doi:10.1016/j.yjmcc.2022.04.013. https://pubmed.ncbi.nlm.nih.gov/35489387/
2. Gao, Yi, Wang, Yanfeng, Wang, Xiaofei, Huang, Chen, Zhang, Jing. 2021. miR-335-5p suppresses gastric cancer progression by targeting MAPK10. In Cancer cell international, 21, 71. doi:10.1186/s12935-020-01684-z. https://pubmed.ncbi.nlm.nih.gov/33482821/
3. Li, Huahui, Li, Yuting, Zhang, Ying, Ermolaeva, Maria A, Fu, Li. 2021. MAPK10 Expression as a Prognostic Marker of the Immunosuppressive Tumor Microenvironment in Human Hepatocellular Carcinoma. In Frontiers in oncology, 11, 687371. doi:10.3389/fonc.2021.687371. https://pubmed.ncbi.nlm.nih.gov/34408980/
4. Tsai, Yuan-Chin, Huang, Chao-Yuan, Hsueh, Yu-Mei, Lu, Te-Ling, Bao, Bo-Ying. 2021. Genetic variants in MAPK10 modify renal cell carcinoma susceptibility and clinical outcomes. In Life sciences, 275, 119396. doi:10.1016/j.lfs.2021.119396. https://pubmed.ncbi.nlm.nih.gov/33774030/
5. Nie, Sipei, Ni, Na, Chen, Ningxin, Liu, Jinhui, Liu, Qiaoling. 2023. Development of a necroptosis-related gene signature and the immune landscape in ovarian cancer. In Journal of ovarian research, 16, 82. doi:10.1186/s13048-023-01155-9. https://pubmed.ncbi.nlm.nih.gov/37095524/
6. Liu, Jiangtao, Li, Yulin. 2019. Upregulation of MAPK10, TUBB2B and RASL11B may contribute to the development of neuroblastoma. In Molecular medicine reports, 20, 3475-3486. doi:10.3892/mmr.2019.10589. https://pubmed.ncbi.nlm.nih.gov/31432180/